Creatin Kinase in serum with clotting activator (Unit: U/l). Bland-Altman plots for selected biomarkers. The difference in measurements is plotted against the average value of both associated measurements. The margins of accuracy as given by the Rili-BAEK are drawn as sloping lines. Agreement is high. Variations are random and no systemical bias through treatment can be detected. Inaccuracy is well within the limits of the Rili-BAEK and within tolerance of clinical interpretation. (PDF 63Â kb
BackgroundThe standard treatment of acute ischemic stroke patients is thrombolytic therapy within 60...
<p><b>7A.</b> Bland-Altman plot showing the difference versus the average of hematocrit (Hct) measur...
creatinine at the point of care offers rapid assessment of renal function, agreement of point-of-car...
Creatin Kinase in Lithium-Heparin preserved serum (Unit: U/l). Bland-Altman plots for selected bioma...
Free Haemoglobin in serum with clotting activator (Unit: mg/l). Bland-Altman plots for selected biom...
INR (Unit: not applicable). Bland-Altman plots for selected biomarkers. The difference in measuremen...
Alpha-HBDH in serum with clotting activator (Unit: U/l) - Two outlying sample pairs have been exclud...
Background Prehospital intravenous access provides the opportunity to sample blood from an emerge...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Linear regression fit of measured vs synthetic ECV at mid-free wall for static hematocrit = 45% mo...
Background: Point-of-care (POC) testing allows for more time-sensitive diagnosis and treatment in th...
BackgroundThe standard treatment of acute ischemic stroke patients is thrombolytic therapy within 60...
<p><b>7A.</b> Bland-Altman plot showing the difference versus the average of hematocrit (Hct) measur...
creatinine at the point of care offers rapid assessment of renal function, agreement of point-of-car...
Creatin Kinase in Lithium-Heparin preserved serum (Unit: U/l). Bland-Altman plots for selected bioma...
Free Haemoglobin in serum with clotting activator (Unit: mg/l). Bland-Altman plots for selected biom...
INR (Unit: not applicable). Bland-Altman plots for selected biomarkers. The difference in measuremen...
Alpha-HBDH in serum with clotting activator (Unit: U/l) - Two outlying sample pairs have been exclud...
Background Prehospital intravenous access provides the opportunity to sample blood from an emerge...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Background: Prehospital intravenous access provides the opportunity to sample blood from an emergenc...
Linear regression fit of measured vs synthetic ECV at mid-free wall for static hematocrit = 45% mo...
Background: Point-of-care (POC) testing allows for more time-sensitive diagnosis and treatment in th...
BackgroundThe standard treatment of acute ischemic stroke patients is thrombolytic therapy within 60...
<p><b>7A.</b> Bland-Altman plot showing the difference versus the average of hematocrit (Hct) measur...
creatinine at the point of care offers rapid assessment of renal function, agreement of point-of-car...